Details for New Drug Application (NDA): 217471
✉ Email this page to a colleague
NDA 217471 describes LOPERAMIDE HYDROCHLORIDE, which is a drug marketed by Aurobindo Pharma Ltd, Bionpharma, Chartwell Rx, Edenbridge Pharms, Jubilant Cadista, Mylan, Roxane, Rubicon, Strides Pharma, Teva, Zydus Lifesciences, Allied, Alpharma Us Pharms, Duramed Pharms Barr, Perrigo, Sciegen Pharms Inc, Watson Labs, Wockhardt Bio Ag, Perrigo R And D, Able, Aurobindo Pharma, Contract Pharmacal, L Perrigo Co, LNK, Ohm Labs, Granules, Guardian Drug, Hetero Labs Ltd V, and Sun Pharm Inds Ltd, and is included in thirty-seven NDAs. It is available from one hundred and four suppliers. Additional details are available on the LOPERAMIDE HYDROCHLORIDE profile page.
The generic ingredient in LOPERAMIDE HYDROCHLORIDE is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.
The generic ingredient in LOPERAMIDE HYDROCHLORIDE is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.
Summary for 217471
| Tradename: | LOPERAMIDE HYDROCHLORIDE |
| Applicant: | Zydus Lifesciences |
| Ingredient: | loperamide hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 217471
| Mechanism of Action | Opioid Agonists |
Medical Subject Heading (MeSH) Categories for 217471
Suppliers and Packaging for NDA: 217471
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LOPERAMIDE HYDROCHLORIDE | loperamide hydrochloride | CAPSULE;ORAL | 217471 | ANDA | Coupler LLC | 67046-1183 | 67046-1183-3 | 30 CAPSULE in 1 BLISTER PACK (67046-1183-3) |
| LOPERAMIDE HYDROCHLORIDE | loperamide hydrochloride | CAPSULE;ORAL | 217471 | ANDA | Zydus Lifesciences Limited | 70771-1769 | 70771-1769-1 | 100 CAPSULE in 1 BOTTLE (70771-1769-1) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 2MG | ||||
| Approval Date: | Mar 23, 2023 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
